16 Patents
- US124286782025Method to Screen for a Mutant Within a Population of Organisms by Applying a Pooling and Splitting Approach
Carlsberg A/S
0 cites - US124102432025Methods of Treating HIV-1 Infection Utilizing Broadly Neutralizing Human Immunodeficiency Virus Type 1 (HIV-1) Gp120-specific Monoclonal Antibodies
Theraclone Sciences Inc.
0 cites - 0 cites
- US123848502025Guidance and Navigation Control Proteins and Method of Making and Using Thereof
SYSTIMMUNE, Inc.
0 cites - US123123962025Monoclonal Antibodies Directed Against Trimeric Forms of the HIV-1 Envelope Glycoprotein with Broad and Potent Neutralizing Activity
The Scripps Research Institute.
0 cites - US120605442024Method for Producing an Extract of Cereal and Method for Processing This Extract Into Beverage
Carlsberg A/S
0 cites - US120297612024Guidance and Navigation Control Proteins and Method of Making and Using Thereof
SYSTIMMUNE, Inc.
0 cites - 0 cites
- US120180672024Monoclonal Antibodies Directed Against Trimeric Forms of the HIV-1 Envelope Glycoprotein with Broad and Potent Neutralizing Activity
Theraclone Sciences, Inc.
0 cites - US119876352024Anti-4-1bb Antibodies and Methods of Making and Using Thereof
BAILI-BIO (CHENGDU) PHARMACEUTICAL CO., Ltd.
0 cites - US118849722024Method to Screen for a Mutant Within a Population of Organisms by Applying a Pooling and Splitting Approach
Carlsberg A/S
0 cites - US118457892023Methods of Treating HIV-1 Infection Utilizing Broadly Neutralizing Human Immunodeficiency Virus Type 1 (HIV-1) Gp120-specific Monoclonal Antibodies
INTERNATIONAL AIDS VACCINE INITIATIVE, Inc.
0 cites - US117878632023Multi-specific Antibodies and Methods of Making and Using Thereof
BAILI-BIO (CHENGDU) PHARMACEUTICAL CO., Ltd.
0 cites - 0 cites
- 0 cites
- US115847892023Monoclonal Antibodies Directed Against Trimeric Forms of the HIV-1 Envelope Glycoprotein with Broad and Potent Neutralizing Activity
THERACLONE SCIENCES, Inc.
0 cites